Crossmark

In silico targeting PAD4 for the treatment of rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1007/s11224-018-1263-5

Published Online: 2019-01-25

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Soni, Mehul N. https://orcid.org/0000-0003-4447-1376
Kumar, Sivakumar Prasanth

Johar SR, Kaid

Pandya, Himanshu A.
Funding

Funding for this research was provided by:

DST (IF150289)
License Information

Text and Data Mining valid from 2019-01-25
More Information

Article History

Received: 12 October 2018

Accepted: 9 December 2018

First Online: 25 January 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study does not contain any studies with human participants or animals performed by any of the authors.